To verify whether the elevation of ADORA2A was a common phenomenon among NE cancers in the lung, we performed IHC staining on a panel of human lung cancer sections including patient samples from 14 patients with LUAD and 19 patients with SCLC. Here, ADORA2A is linked to lung cancer.